American Healthcare REIT, Inc. (AHR)
NYSE: AHR · Real-Time Price · USD
50.11
+0.14 (0.28%)
At close: Dec 5, 2025, 4:00 PM EST
50.90
+0.79 (1.58%)
After-hours: Dec 5, 2025, 7:57 PM EST
American Healthcare REIT Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for American Healthcare REIT stock have an average target of 51.8, with a low estimate of 37 and a high estimate of 60. The average target predicts an increase of 3.37% from the current stock price of 50.11.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for American Healthcare REIT stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 3 | 3 | 3 |
| Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $46 → $53 | Strong Buy | Maintains | $46 → $53 | +5.77% | Nov 26, 2025 |
| Citigroup | Citigroup | Hold Maintains $45 → $52 | Hold | Maintains | $45 → $52 | +3.77% | Nov 21, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $52 → $55 | Buy | Maintains | $52 → $55 | +9.76% | Nov 20, 2025 |
| UBS | UBS | Strong Buy Maintains $51 → $56 | Strong Buy | Maintains | $51 → $56 | +11.75% | Nov 17, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $47 → $55 | Buy | Maintains | $47 → $55 | +9.76% | Nov 13, 2025 |
Financial Forecast
Revenue This Year
2.26B
from 2.06B
Increased by 9.41%
Revenue Next Year
2.47B
from 2.26B
Increased by 9.26%
EPS This Year
0.42
from -0.29
EPS Next Year
0.73
from 0.42
Increased by 73.89%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 2.4B | 2.8B | ||
| Avg | 2.3B | 2.5B | ||
| Low | 2.1B | 2.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 17.8% | 26.0% | ||
| Avg | 9.4% | 9.3% | ||
| Low | 3.7% | 0.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.56 | 0.84 | |
| Avg | 0.42 | 0.73 | |
| Low | 0.30 | 0.57 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 99.2% | |
| Avg | - | 73.9% | |
| Low | - | 34.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.